Correction to: J Exp Clin Cancer Res 35, 21 (2016)
https://doi.org/10.1186/s13046-016-0287-1
Anzeige
Following publication of the original article [1], the authors identified minor errors in image-typesetting in Figs. 3 and 4; specifically:
Fig. 3
c Representative images (left) and quantification (right) of migrated cells across a Transwell chamber
Fig. 4
GSK3β and SFRP2 are the bona fide effector of miR-224 in vivo. a Tumor xenograft model. Cells were injected into the hindlimbs of nude mice (n = 6). Representative images of the tumors are shown. b Tumor volumes were measured on the indicated days. Data points are presented as the mean tumor volume ± SD. c Histopathology of xenograft tumors. The tumor sections were under H&E staining and IHC staining using antibody against Ki-67. d The percentage of Ki67 positive cells. Error bars represent mean ± SD from 3 independent experiments; * p < 0.05, ** p < 0.01
×
×
3C: miR-224/GSK3B/SFRP2 group (top and bottom right panel)
4A: figure adjusted to show only areas of the body containing the tumour
4C: H&E staining in the NC group (top left)
Anzeige
The corrected figures are given below. The corrections do not have any effect on the results or conclusions of the paper. The original article has been corrected.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.
Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.
Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.
In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.
Update Onkologie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
